Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease-Reference-Cited by-同舟云学术

Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease

Published:2015-07-14 Issue:2 Volume:314 Page:142
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Pandya Ankur¹,Sy Stephen¹,Cho Sylvia¹,Weinstein Milton C.¹,Gaziano Thomas A.²

Affiliation:

1. Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts

2. Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts2Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age and sex specific thresholds for risk stratification of cardiovascular disease and clinical decision making: prospective open cohort study;BMJ Medicine;2024-08

2. Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations;JAMA;2024-07-29

3. Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population;PLOS ONE;2024-07-19

4. The LDL cumulative exposure hypothesis: evidence and practical applications;Nature Reviews Cardiology;2024-07-05

5. Comparison of atherosclerotic cardiovascular disease (ASCVD) and Framingham risk scores (FRS) in an Iranian population;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-06